Virbac SA
OTC:VRBCF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Virbac SA
OTC:VRBCF
|
FR |
|
M
|
Magnum Ice Cream Company NV
AEX:MICC
|
NL |
|
U
|
UACJ Corp
F:F4M
|
JP |
|
H
|
Hormel Foods Corp
XMUN:HO7
|
US |
|
G
|
Gen Digital Inc
DUS:SYM
|
US |
|
Gail (India) Ltd
OTC:GAILF
|
IN |
|
IPH Ltd
F:1IP
|
AU |
|
Compass Minerals International Inc
NYSE:CMP
|
US |
|
Z
|
Zinitix Co Ltd
KOSDAQ:303030
|
KR |
|
V
|
Vilkyskiu Pienine AB
XMUN:UDW
|
LT |
|
Ternium SA
NYSE:TX
|
LU |
Intrinsic Value
Is VRBCF undervalued or overvalued?
See the intrinsic value estimate for 
Virbac SA and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Virbac Does
Virbac SA is an animal health company. It makes and sells medicines, vaccines, diagnostic products, and other care products for pets and farm animals. Its lineup includes treatments for parasites, skin and ear conditions, vaccines, and veterinary nutrition products.
- Headquarters
- France FR
- Employees
- 6 442
- IPO date
- Jan 1, 1985
Virbac has no economic moat
Virbac SA lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.
Read the full moat analysis
Earnings Waterfall
Virbac SA
The intrinsic value for Virbac SA (VRBCF) under the Base Case is hidden USD.
Compared with the current market price of 383.25 USD, the stock appears hidden.